Exploration of the genes responsible for unlimited proliferation of immortalized lung fibroblasts

Experimental Lung Research

Volumn 34, Issue 7, 2008, Pages 373-390

  Hiyama, Keiko ^a   Tanimoto, Keiji ^a   Nishimura, Youhei ^a   Tsugane, Momomi ^a   Fukuba, Ikuko ^a   Sotomaru, Yusuke ^a   Hiyama, Eiso ^a   Nishiyama, Masahiko ^a,b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Growth regulation; Lung fibroblast; Microarray; Proliferation; Telomerase

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CELL GROWTH; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL STRAIN; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GROWTH REGULATION; HUMAN; HUMAN CELL; LIFESPAN; LUNG FIBROBLAST; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL ADHESION; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; LUNG; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASMS, EXPERIMENTAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLOIDIES; TELOMERASE; TELOMERE; TIME FACTORS; TRANSFECTION;

EID: 50049089875     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140802221912     Document Type: Article

References (31)

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med. 2002;165:277-304.
2. King TE Jr: Idiopathic interstitial pneumonias: translating our current understanding into novel therapies. Exp Lung Res. 2005;31(Suppl 1):41-46.
3. Martinez FJ, Keane MP: Update in diffuse parenchymal lung diseases 2005. Am J Respir Crit Care Med. 2006;173:1066-1071.
4. Tsakiri KD, Cronkhite JT, Kuan PJ, Xing C, Raghu G, Weissler JC, et al: Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci USA. 2007;104:7552-7557.
5. Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, Markin C, et al: Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med. 2007;356:1317-1326.
6. Harley CB: Telomere loss: mitotic clock or genetic time bomb? Mutat Res. 1991;256:271-282.
7. Shay JW, Wright WE: Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis. 2005;26:867-874.
8. Forsyth NR, Evans AP, Shay JW, Wright WE: Developmental differences in the immortalization of lung fibroblasts by telomerase. Aging Cell. 2003;2:235-243.
9. Zuo F, Kaminski N, Eugui E, Allard J, Yakhini Z, Ben-Dor A, et al: Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci USA. 2002;99:6292-6297.
10. Selman M, Pardo A, Barrera L, Estrada A, Watson SR, Wilson K, et al: Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2006;173:188-198.
11. Yang IV, Burch LH, Steele MP, Savov JD, Hollingsworth JW, McElvania-Tekippe E, et al: Gene expression profiling of familial and sporadic interstitial pneumonia. Am J Respir Crit Care Med. 2007;175:45-54.
12. Kumazaki T, Hiyama K, Takahashi T, Omatsu H, Tanimoto K, Noguchi T, et al: Differential gene expressions during immortalization of normal human fibroblasts and endothelial cells transfected with human telomerase reverse transcriptase gene. Int J Oncol. 2004;24:1435-1442.
13. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, et al: Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet. 1998;18:65-68.
14. Tsuyama N, Miura M, Kitahira M, Ishibashi S, Ide T: SV40 T-antigen is required for maintenance of immortal growth in SV40-transformed human fibroblasts. Cell Struct Funct. 1991;16:55-62.
15. Ohtsu K, Hiyama E, Ichikawa T, Matsuura Y, Yokoyama T: Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1. Clin Cancer Res. 1997;3:1221-1228.
16. Huang J, Hamasaki H, Nakamoto T, Honda H, Hirai H, Saito M, et al: Differential regulation of cell migration, actin stress fiber organization, and cell transformation by functional domains of Crk-associated substrate. J Biol Chem. 2002;277:27265-27272.
17. Ouellette MM, Aisner DL, Savre-Train I, Wright WE, Shay JW: Telomerase activity does not always imply telomere maintenance. Biochem Biophys Res Commun. 1999;254:795-803.
18. Rogulski K, Li Y, Rothermund K, Pu L, Watkins S, Yi F, et al: Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt-Mdm2-p53 pathway. Oncogene. 2005;24:7524-7541.
19. Ashida S, Nakagawa H, Katagiri T, Furihata M, Iiizumi M, Anazawa Y, et al: Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Res. 2004;64:5963-5972.
20. Nielsen HL, Ronnov-Jessen L, Villadsen R, Petersen OW: Identification of EPSTI1, a novel gene induced by epithelial-stromal interaction in human breast cancer. Genomics. 2002;79:703-710.
21. Suomela S, Cao L, Bowcock A, Saarialho-Kere U: Interferon alpha-inducible protein 27 (IFI27) is upregulated in psoriatic skin and certain epithelial cancers. J Invest Dermatol. 2004;122:717-721.
22. Kuan CT, Wakiya K, Dowell JM, Herndon JE, 2nd, Reardon DA, Graner MW, et al: Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme. Clin Cancer Res. 2006;12:1970-1982.
23. Vantomme V, Boel P, De Plaen E, Boon T, van der Bruggen P: A new tumor-specific antigenic peptide encoded by MAGE-6 is presented to cytolytic T lymphocytes by HLA-Cw16. Cancer Immun. 2003;3:17.
24. Yu L, Liu H, Yan M, Yang J, Long F, Muneoka K, et al: Shox2 is required for chondrocyte proliferation and maturation in proximal limb skeleton. Dev Biol. 2007;306:549-59.
25. Yageta M, Kuramochi M, Masuda M, Fukami T, Fukuhara H, Maruyama T, et al: Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer. Cancer Res. 2002;62:5129-5133.
26. Heller G, Geradts J, Ziegler B, Newsham I, Filipits M, Markis-Ritzinger EM, et al: Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer. Breast Cancer Res Treat. 2007;103:283-291.
27. Karlsson C, Brantsing C, Svensson T, Brisby H, Asp J, Tallheden T, et al: Differentiation of human mesenchymal stem cells and articular chondrocytes: analysis of chondrogenic potential and expression pattern of differentiation-related transcription factors. J Orthop Res. 2007;25:152-163.
28. Aoki F, Kurabayashi M, Hasegawa Y, Kojima I: Attenuation of bleomycin-induced pulmonary fibrosis by follistatin. Am J Respir Crit Care Med. 2005;172:713-720.
29. Geigl JB, Langer S, Barwisch S, Pfleghaar K, Lederer G, Speicher MR: Analysis of gene expression patterns and chromosomal changes associated with aging. Cancer Res. 2004;64:8550-8557.
30. Mohr LC: Hypersensitivity pneumonitis. Curr Opin Pulm Med. 2004;10:401-411.
31. Selman M, Pardo A: Idiopathic pulmonary fibrosis: misunderstandings between epithelial cells and fibroblasts? Sarcoidosis Vasc Diffuse Lung Dis. 2004;21:165-172.